CAMBRIDGE, Mass., May 2, 2024 /PRNewswire/ -- ONO PHARMA USA today announced partnerships with LabCentral in Cambridge, Mass., and MBC BioLabs in San Francisco and San Carlos, CA to award each organization one Golden Ticket for an innovative life sciences startup company. The competition is sponsored by ONO PHARMA USA's parent company, Ono Pharmaceutical Co., Ltd. (Ono), and applications will be received through May 2024.
Japan`s Ono to buy US drugmaker Deciphera for $2.4 bln
Deciphera Pharmaceuticals to be Acquired by ONO Pharmaceutical For $2.4 Billion
Sibylla Biotech Enters a Drug Discovery Collaboration with Ono Pharmaceutical
Ono Enters into a Research Collaboration Agreement with InveniAI
NM49 is a multi-specific antibody identified through Numab™s proprietary discovery and engineering technology platform designed to activate tumor associated macrophage phagocytosis Numab to receive...
AUSTIN, TX and DURHAM, NC, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bifunctional fusion...
OSAKA, Japan, Jan. 9, 2024 /PRNewswire/ -- Ono Pharmaceutical Co., Ltd. (Osaka, Japan) informed that it has started a new collaboration with BioMed X (Heidelberg, Germany) on cancer immunotherapies and has been inviting researchers who are interested in this research project via BioMed X.